WebJan 18, 2024 · Pembrolizumab (Keytruda) monotherapy demonstrated durable antitumor activity and encouraging effects on survival in an evaluation of patients with previously … WebNov 5, 2024 · Conclusions: With median of follow-up >5 y, pembro monotherapy demonstrated sustained antitumor activity in pts with R/R cHL. ORRs were high and responses durable in the overall population and in those with varied treatment histories. Pts with CR had especially durable responses, and in those relapsing from CR, 2nd-course …
Pembrolizumab shows notable antitumour activity for patients …
WebJun 13, 2024 · Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial Clin … WebMar 30, 2024 · O'Malley DM, Bariani GM, Cassier PA, Marabelle A, Hansen AR, De Jesus Acosta A, Miller WH Jr, Safra T, Italiano A, Mileshkin L, Amonkar M, Yao L, Jin F, Norwood … sensory trail activities
Moderna and Merck Announce mRNA-4157/V940, an …
WebDec 3, 2024 · First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): updated results for KEYNOTE-427 cohort A. J Clin Oncol. 2024 May;37(15_suppl):4570. ASCO Family of Sites. Journals. Journal of Clinical Oncology JCO Oncology Practice JCO Global Oncology JCO Clinical Cancer Informatics JCO Precision … WebApr 1, 2024 · Pembrolizumab monotherapy demonstrated a clinically meaningful survival benefit and durable antitumor activity in patients with PD-L1 combined positive score (CPS) ≥10 gastric or gastroesophageal junction cancer from KEYNOTE-059 cohort 1 (n = 46; third-line or later setting), KEYNOTE-061 (n = 53; second-line setting), and KEYNOTE-062 (n = … WebMay 25, 2024 · 8005. Background: PD-1 blockade via pembro monotherapy showed antitumor activity in R/R cHL. KEYNOTE-204 (NCT02684292) was a randomized, international, open-label, phase III study of pembro vs BV in R/R cHL. Methods: Patients (pts) were aged ≥18 y, were post−autologous stem cell transplant (auto-SCT) or ineligible for … sensory trail national trust